heart disease: be developed

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents lung cancer
Weight: 0.84
, mental illness
Weight: 0.76
, prostate cancer
Weight: 0.76
, mental health problem
Weight: 0.75
, respiratory system
Weight: 0.74
Siblings breast cancer
Weight: 0.75
, diabetes
Weight: 0.65
, disease
Weight: 0.65
, rheumatoid arthritis
Weight: 0.38
, dementia
Weight: 0.37

Related properties

Property Similarity
be developed 1.00
be more common in developed world 0.84
be more common in developed countries 0.82
develop 0.81
be created 0.78
was created 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.09
Rule weight: 0.13
Evidence weight: 0.79
Similarity weight: 0.82
Evidence: 0.42
¬ Remarkable(heart disease, be developed)
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
0.08
Rule weight: 0.13
Evidence weight: 0.64
Similarity weight: 1.00
Evidence: 0.42
¬ Remarkable(heart disease, be developed)
Evidence: 0.85
¬ Remarkable(breast cancer, be developed)
0.08
Rule weight: 0.13
Evidence weight: 0.70
Similarity weight: 0.81
Evidence: 0.42
¬ Remarkable(heart disease, be developed)
Evidence: 0.71
¬ Remarkable(diabetes, develop)
0.07
Rule weight: 0.13
Evidence weight: 0.66
Similarity weight: 0.78
Evidence: 0.42
¬ Remarkable(heart disease, be developed)
Evidence: 0.81
¬ Remarkable(disease, be created)
0.06
Rule weight: 0.13
Evidence weight: 0.63
Similarity weight: 0.76
Evidence: 0.42
¬ Remarkable(heart disease, be developed)
Evidence: 0.86
¬ Remarkable(breast cancer, was created)

Remarkability from sibling implausibility

0.58
Rule weight: 0.60
Evidence weight: 0.97
Similarity weight: 1.00
Evidence: 0.32
Plausible(heart disease, be developed)
Evidence: 0.85
Remarkable(breast cancer, be developed)
Evidence: 0.29
¬ Plausible(breast cancer, be developed)
0.45
Rule weight: 0.60
Evidence weight: 0.91
Similarity weight: 0.81
Evidence: 0.32
Plausible(heart disease, be developed)
Evidence: 0.71
Remarkable(diabetes, develop)
Evidence: 0.44
¬ Plausible(diabetes, develop)
0.44
Rule weight: 0.60
Evidence weight: 0.94
Similarity weight: 0.78
Evidence: 0.32
Plausible(heart disease, be developed)
Evidence: 0.81
Remarkable(disease, be created)
Evidence: 0.44
¬ Plausible(disease, be created)
0.44
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 0.76
Evidence: 0.32
Plausible(heart disease, be developed)
Evidence: 0.86
Remarkable(breast cancer, was created)
Evidence: 0.54
¬ Plausible(breast cancer, was created)
0.41
Rule weight: 0.60
Evidence weight: 0.83
Similarity weight: 0.82
Evidence: 0.32
Plausible(heart disease, be developed)
Evidence: 0.48
Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.49
¬ Plausible(breast cancer, be more common in developed countries)

Salient implies Plausible

0.22
Rule weight: 0.28
Evidence weight: 0.78
Similarity weight: 1.00
Evidence: 0.32
Plausible(heart disease, be developed)
Evidence: 0.32
¬ Salient(heart disease, be developed)

Similarity expansion

0.65
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.84
Evidence: 0.42
Remarkable(heart disease, be developed)
Evidence: 0.16
¬ Remarkable(heart disease, be more common in developed world)
0.64
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.84
Evidence: 0.32
Plausible(heart disease, be developed)
Evidence: 0.16
¬ Plausible(heart disease, be more common in developed world)
0.64
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.84
Evidence: 0.32
Salient(heart disease, be developed)
Evidence: 0.16
¬ Salient(heart disease, be more common in developed world)
0.61
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.82
Evidence: 0.42
Remarkable(heart disease, be developed)
Evidence: 0.23
¬ Remarkable(heart disease, be more common in developed countries)
0.58
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.82
Evidence: 0.32
Salient(heart disease, be developed)
Evidence: 0.25
¬ Salient(heart disease, be more common in developed countries)
0.55
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.82
Evidence: 0.32
Plausible(heart disease, be developed)
Evidence: 0.32
¬ Plausible(heart disease, be more common in developed countries)
0.54
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.84
Evidence: 0.40
Typical(heart disease, be developed)
Evidence: 0.41
¬ Typical(heart disease, be more common in developed world)
0.48
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.82
Evidence: 0.40
Typical(heart disease, be developed)
Evidence: 0.54
¬ Typical(heart disease, be more common in developed countries)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.88
Similarity weight: 1.00
Evidence: 0.32
Salient(heart disease, be developed)
Evidence: 0.40
¬ Typical(heart disease, be developed)
Evidence: 0.42
¬ Remarkable(heart disease, be developed)

Typical implies Plausible

0.35
Rule weight: 0.48
Evidence weight: 0.73
Similarity weight: 1.00
Evidence: 0.32
Plausible(heart disease, be developed)
Evidence: 0.40
¬ Typical(heart disease, be developed)

Typicality and Rermarkability incompatibility between siblings

0.13
Rule weight: 0.14
Evidence weight: 0.94
Similarity weight: 1.00
Evidence: 0.42
¬ Remarkable(heart disease, be developed)
Evidence: 0.14
¬ Typical(breast cancer, be developed)
0.09
Rule weight: 0.14
Evidence weight: 0.83
Similarity weight: 0.81
Evidence: 0.42
¬ Remarkable(heart disease, be developed)
Evidence: 0.41
¬ Typical(diabetes, develop)
0.09
Rule weight: 0.14
Evidence weight: 0.85
Similarity weight: 0.78
Evidence: 0.42
¬ Remarkable(heart disease, be developed)
Evidence: 0.36
¬ Typical(disease, be created)
0.08
Rule weight: 0.14
Evidence weight: 0.82
Similarity weight: 0.76
Evidence: 0.42
¬ Remarkable(heart disease, be developed)
Evidence: 0.43
¬ Typical(breast cancer, was created)
0.08
Rule weight: 0.14
Evidence weight: 0.75
Similarity weight: 0.82
Evidence: 0.42
¬ Remarkable(heart disease, be developed)
Evidence: 0.58
¬ Typical(breast cancer, be more common in developed countries)